IL223584A0 - Crystalline form of a 3-phenoxymethylpyrrolidine compounds - Google Patents

Crystalline form of a 3-phenoxymethylpyrrolidine compounds

Info

Publication number
IL223584A0
IL223584A0 IL223584A IL22358412A IL223584A0 IL 223584 A0 IL223584 A0 IL 223584A0 IL 223584 A IL223584 A IL 223584A IL 22358412 A IL22358412 A IL 22358412A IL 223584 A0 IL223584 A0 IL 223584A0
Authority
IL
Israel
Prior art keywords
crystalline form
phenoxymethylpyrrolidine
compounds
phenoxymethylpyrrolidine compounds
crystalline
Prior art date
Application number
IL223584A
Other languages
English (en)
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44510052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL223584(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of IL223584A0 publication Critical patent/IL223584A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL223584A 2010-07-09 2012-12-12 Crystalline form of a 3-phenoxymethylpyrrolidine compounds IL223584A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36277310P 2010-07-09 2010-07-09
PCT/US2011/042518 WO2012006205A1 (en) 2010-07-09 2011-06-30 Crystalline form of a 3-phenoxymethylpyrrolidine compound

Publications (1)

Publication Number Publication Date
IL223584A0 true IL223584A0 (en) 2013-03-05

Family

ID=44510052

Family Applications (1)

Application Number Title Priority Date Filing Date
IL223584A IL223584A0 (en) 2010-07-09 2012-12-12 Crystalline form of a 3-phenoxymethylpyrrolidine compounds

Country Status (20)

Country Link
US (4) US8163794B2 (enExample)
EP (1) EP2590941A1 (enExample)
JP (2) JP5823512B2 (enExample)
KR (1) KR20130041916A (enExample)
CN (1) CN103038211B (enExample)
AR (1) AR083512A1 (enExample)
AU (1) AU2011276416B2 (enExample)
BR (1) BR112013000602A2 (enExample)
CA (1) CA2803090A1 (enExample)
CL (1) CL2013000085A1 (enExample)
CO (1) CO6680604A2 (enExample)
IL (1) IL223584A0 (enExample)
MX (1) MX2013000334A (enExample)
NZ (1) NZ605490A (enExample)
PH (1) PH12013500051A1 (enExample)
RU (1) RU2013105479A (enExample)
SG (1) SG186789A1 (enExample)
TW (1) TW201206882A (enExample)
WO (1) WO2012006205A1 (enExample)
ZA (1) ZA201300154B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2535669C2 (ru) * 2009-07-13 2014-12-20 Тереванс, Инк. 3-феноксиметилпирролидиновые соединения
NZ605490A (en) * 2010-07-09 2014-10-31 Theravance Biopharma R & D Ip Llc Crystalline form of a 3-phenoxymethylpyrrolidine compound
US12369722B2 (en) 2018-05-23 2025-07-29 L&P Property Management Company Method of disassembling pocketed spring assembly with dimensionally stabilizing substrate
US11013340B2 (en) 2018-05-23 2021-05-25 L&P Property Management Company Pocketed spring assembly having dimensionally stabilizing substrate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151712A1 (en) 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
DE60119047D1 (de) * 2000-08-31 2006-06-01 Pfizer Phenoxyphenylheterozyklen als Serotonin-Wiederaufnahmehemmer
EP1725518A1 (en) * 2004-03-05 2006-11-29 Eli Lilly And Company Pharmaceutical compounds
CA2661187A1 (en) * 2006-08-23 2008-02-28 Pfizer Products Inc. Piperidine derivatives
US20100292288A1 (en) * 2007-06-08 2010-11-18 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-1-{2-[4`- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
JP5405571B2 (ja) * 2008-07-24 2014-02-05 セラヴァンス, インコーポレーテッド 3−(フェノキシフェニルメチル)ピロリジン化合物
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
RU2535669C2 (ru) * 2009-07-13 2014-12-20 Тереванс, Инк. 3-феноксиметилпирролидиновые соединения
NZ605490A (en) * 2010-07-09 2014-10-31 Theravance Biopharma R & D Ip Llc Crystalline form of a 3-phenoxymethylpyrrolidine compound

Also Published As

Publication number Publication date
US8791151B2 (en) 2014-07-29
CN103038211B (zh) 2015-04-15
CN103038211A (zh) 2013-04-10
JP5823512B2 (ja) 2015-11-25
AU2011276416B2 (en) 2015-04-02
US20150080450A1 (en) 2015-03-19
KR20130041916A (ko) 2013-04-25
WO2012006205A1 (en) 2012-01-12
CL2013000085A1 (es) 2013-03-15
BR112013000602A2 (pt) 2016-07-05
US20120010265A1 (en) 2012-01-12
EP2590941A1 (en) 2013-05-15
US9120746B2 (en) 2015-09-01
US20120178790A1 (en) 2012-07-12
US20140018407A1 (en) 2014-01-16
PH12013500051A1 (en) 2017-10-25
JP2015120752A (ja) 2015-07-02
CO6680604A2 (es) 2013-05-31
MX2013000334A (es) 2013-02-26
US8163794B2 (en) 2012-04-24
AU2011276416A1 (en) 2013-02-14
SG186789A1 (en) 2013-02-28
NZ605490A (en) 2014-10-31
US8383669B2 (en) 2013-02-26
ZA201300154B (en) 2013-09-25
CA2803090A1 (en) 2012-01-12
RU2013105479A (ru) 2014-08-20
AR083512A1 (es) 2013-03-06
TW201206882A (en) 2012-02-16
JP2013532170A (ja) 2013-08-15

Similar Documents

Publication Publication Date Title
GB201001075D0 (en) Crystalline forms
PT2576505T (pt) Processo para a preparação de pleuromutilinas
GB201005589D0 (en) Novel compounds
GB201007203D0 (en) Novel compounds
PT2611779T (pt) Formas cristalinas de um inibidor do fator xa
SI2603509T1 (sl) Kristalinična oblika spojine PIRIMIDIO(6,1-A) IZOKINOLIN-4-ENA
PL2453894T3 (pl) Postać krystaliczna wolnej zasady związku bifenylowego
PL2578595T3 (pl) Krystaliczna lewoizowalerylospiramycyna I
SI2739621T1 (sl) Kristali 2-acilaminotiazol spojine
SG10201501226VA (en) New crystalline form of a cyclopropyl benzamide derivative
IL223584A0 (en) Crystalline form of a 3-phenoxymethylpyrrolidine compounds
ZA201406238B (en) Crystalline form of a succinate salt
IL230977A (en) A crystalline form of relapaldib
TWM390844U (en) Structure improvement of a screwdriver
GB201007791D0 (en) Novel compounds
GB201108347D0 (en) Polymprphic form of compound
TWM402641U (en) Structure of a place box
HUE050301T2 (hu) 2-Acilamino-tiazol-vegyület kristályok
TWM385440U (en) Structure improvement of a screwdriver
GB201006847D0 (en) Novel compounds
GB201002811D0 (en) Novel compounds
GB201002801D0 (en) Novel compounds
GB201002799D0 (en) Novel compounds
GB201002797D0 (en) Novel compounds
GB201002112D0 (en) Novel compounds